BCL2 and cancer: The BCL2 inhibitors ABT-737 and ABT-199 had no inhibitory effects on miRNA-17 and miRNA-20b expression (S2 Fig); these miRNAs were investigated because they were significantly upregulated in the cancer miRNA array (Fig 1A).